Characteristic | Intervention | Control | RR (95% CI) |
---|---|---|---|
All children treated by CHWs | N = 609 | N = 667 | |
Overall treatment failure | 90 (14.8%) | 101 (15.1%) | 0.88 (0.67-1.18) |
Received additional* antibiotics | 7 (1.2%) | 13 (2.0%) | 0.77 (0.32-1.86) |
Received additional** anti-malarials | 4 (0.7%) | 10 (1.5%) | 0.44 (0.15-1.28) |
Hospitalization | 10 (1.6%) | 9 (1.4%) | 1.47 (0.64-3.38) |
Temperature ≥ 37.5°C on day 4 | 7 (1.2%) | 23 (3.5%) | 0.29 (0.11-0.78) |
Had fast breathing on day 4 | 66 (10.8%) | 48 (7.2%) | 1.29 (0.87-1.92) |
Difference in fast breathing, day 1& 4† | 9.2% | 4.2% | p-value = 0.01 |
Self reported treatment failure | 83 (13.7%) | 170 (25.5%) | 0.58 (0.46-0.74) |
Children with malaria symptoms | |||
Characteristic | Intervention | Control | RR (95% CI) |
n = 589 | n = 647 | ||
Overall treatment failure in malaria | 84 (14.3%) | 99 (15.3%) | 0.85 (0.64-1.13) |
Received additional* antibiotics | 6 (1.0%) | 13 (2.0%) | 0.65 (0.26-1.65) |
Received additional** anti-malarials | 3 (0.5%) | 10 (1.6%) | 0.35 (0.11-1.11) |
Hospitalization | 9 (1.5%) | 9 (1.4%) | 1.36 (0.59-3.16) |
Temperature ≥ 37.5°C on day 4 | 7 (1.2%) | 22 (3.4%) | 0.30 (0.11-0.81) |
Had fast breathing on day 4 | 62 (10.5%) | 48 (7.4%) | 1.22 (0.82-1.82) |
Difference in fast breathing, day 1& 4,† | 9.5% | 4.0% | p-value = 0.006 |
Self reported treatment failure | 78 (13.3%) | 168 (26.0%) | 0.56 (0.44-0.71) |
Children with self reported pneumonia symptoms | |||
Characteristic | Intervention | Control | RR (95% CI) |
n = 251 | n = 279 | ||
Overall treatment failure in “pneumonia” | 43 (17.1%) | 56 (20.1%) | 0.77 (0.52-1.13) |
Received additional* antibiotics | 2 (0.8%) | 10 (3.6%) | 0.30 (0.08-1.21) |
Received additional** anti-malarials | 0 (0) | 8 (2.9%) | - |
Hospitalization | 4 (1.6%) | 3 (1.1%) | 2.42 (0.60-9.84) |
Temperature ≥ 37.5°C on day 4 | 5 (2.0%) | 11 (3.9%) | 0.41 (0.10-1.75) |
Had fast breathing on day 4 | 34 (13.6%) | 25 (9.0%) | 1.30 (0.76-2.21) |
Difference in fast breathing, day 1& 4 † | 18.3% | 3.6% | p-value < 0.001 |
Self reported treatment failure | 22 (8.8) | 74 (26.5) | 0.35 (0.22-0.56) |